Agilent Technologies, Inc. (A)
A moved a median of +0.01% 30 minutes after news, and +0.15% by the close. How A actually reacts to news — the realized, point-in-time move the market made, measured across 498 labeled events over the last three years with zero look-ahead.
A’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.05% | 58% | 496 |
| 30-min | +0.01% | 50% | 496 |
| 60-min | +0.03% | 51% | 496 |
| to close | +0.15% | 57% | 496 |
| Middle 50% of A reactions | -0.33% to +0.45% |
|---|---|
| Median reaction (30-min) | +0.01% |
| Measured reactions | 498 |
Half of all Agilent Technologies, Inc. news events land between -0.33% and +0.45% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How A reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 34 | -0.01% | 47% | +0.18% |
| Analyst downgrades | 12 | -0.04% | 50% | -0.23% |
| Coverage initiations | 35 | +0.41% | 77% | -0.33% |
| Rating reiterations | 100 | +0.05% | 55% | -0.08% |
| Price-target raises | 53 | +0.11% | 59% | -0.09% |
| Price-target cuts | 33 | -0.07% | 49% | -0.13% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how A ranks against every other measured name →
That’s how A usually reacts — get an email when it moves on news →Email me when A moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to A's baseline. Nothing else.
Recent A events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence | Press release | Business Wire | -0.42% | -0.16% | |
| Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows | Press release | Business Wire | -0.66% | -3.09% | |
| Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers | Press release | Business Wire | +1.27% | +0.31% | |
| Form EFFECT AGILENT TECHNOLOGIES, | SEC filing · Form EFFECT | SEC EDGAR | +1.50% | +5.42% | |
| Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control | Press release | Business Wire | -0.21% | +2.58% | |
| Agilent Announces Cash Dividend of 25.5 Cents per Share | Press release | Business Wire | -1.04% | +0.22% | |
| Agilent to Participate in J.P. Morgan U.S. All Stars Conference | Press release | Business Wire | +0.65% | +1.70% | |
| Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors | Press release | Business Wire | +0.66% | -0.79% | |
| Form 8-K AGILENT TECHNOLOGIES, For: Sep 02 | SEC filing · Form 8-K | SEC EDGAR | +0.66% | -0.79% | |
| Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System | Press release | Business Wire | -0.46% | +1.49% | |
| Agilent Introduces the Cary 635 FTIR Spectrometer | Press release | Business Wire | -1.26% | -3.01% | |
| Form 10-Q AGILENT TECHNOLOGIES, For: Jul 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.83% | +1.57% | |
| Form S-3ASR AGILENT TECHNOLOGIES, | SEC filing · Form S-3ASR | SEC EDGAR | +0.83% | +1.57% | |
| Form S-4 AGILENT TECHNOLOGIES, | SEC filing · Form S-4 | SEC EDGAR | +0.83% | +1.57% | |
| Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results | Press release | Business Wire | -3.35% | -3.70% | |
| Form 8-K AGILENT TECHNOLOGIES, For: Aug 26 | SEC filing · Form 8-K | SEC EDGAR | -3.35% | -3.70% | |
| Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo | Press release | Business Wire | -0.13% | -0.99% | |
| Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26 | Press release | Business Wire | -0.13% | -0.99% | |
| Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma | Press release | Business Wire | +0.31% | -0.19% | |
| Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma | Press release | Business Wire | -0.84% | +0.86% | |
| Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis | Press release | Business Wire | -0.96% | -0.01% | |
| Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight | Press release | Business Wire | +0.51% | +0.30% | |
| Agilent Completes Acquisition of Biocare Medical | Press release | Business Wire | +1.89% | +1.17% | |
| Form 8-K AGILENT TECHNOLOGIES, For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +1.31% | +0.62% | |
| Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation | Press release | Business Wire | +0.44% | +2.09% | |
| Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma | Press release | Business Wire | +0.44% | +2.09% | |
| Form 10-Q AGILENT TECHNOLOGIES, For: Apr 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.99% | +1.53% | |
| Form SD AGILENT TECHNOLOGIES, | SEC filing · Form SD | SEC EDGAR | +0.36% | +1.86% | |
| Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory | Press release | Business Wire | -1.25% | +0.28% | |
| Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results | Press release | Business Wire | -1.25% | +0.28% | |
| Form 8-K AGILENT TECHNOLOGIES, For: May 20 | SEC filing · Form 8-K | SEC EDGAR | -1.25% | +0.28% | |
| Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control | Press release | Business Wire | -0.52% | +0.46% | |
| Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality | Press release | Business Wire | -0.52% | +0.46% | |
| Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis | Press release | Business Wire | -0.16% | -0.06% | |
| Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed | Press release | Business Wire | -0.42% | +1.95% | |
| Agilent Announces Cash Dividend of 25.5 Cents per Share | Press release | Business Wire | -0.42% | +1.95% | |
| Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research | Press release | PR Newswire | -2.27% | +2.32% | |
| Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026 | Press release | Business Wire | -0.59% | -1.29% | |
| Agilent to Participate in Jefferies Global Healthcare Conference | Press release | Business Wire | +0.13% | +0.88% | |
| Agilent Names Michael Buckner as Chief Legal Officer | Press release | Business Wire | +0.84% | -1.15% | |
| Form 8-K AGILENT TECHNOLOGIES, For: May 04 | SEC filing · Form 8-K | SEC EDGAR | +0.84% | -1.15% | |
| Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27 | Press release | Business Wire | +1.17% | -2.53% | |
| Agilent Showcases Cancer Research Solutions at AACR 2026 | Press release | Business Wire | +0.28% | -0.52% | |
| Form 8-K/A AGILENT TECHNOLOGIES, For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | -0.63% | -0.35% | |
| Form 8-K AGILENT TECHNOLOGIES, For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | -0.63% | -0.35% | |
| Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader | Press release | Business Wire | +0.36% | +0.47% | |
| Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma | Press release | Business Wire | -0.31% | -0.54% | |
| Form 8-K AGILENT TECHNOLOGIES, For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | -0.85% | -1.23% | |
| Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026 | Press release | Business Wire | +1.02% | +0.98% | |
| Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States | Press release | Business Wire | +0.41% | -0.14% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the A section they belong to.
Where else A is measured.
A earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Teligent, Inc. (TLGT) | 502 | -0.17% | 43% |
| Zealand Pharma A/S - American Depositary Shares (ZEAL) | 502 | 0.00% | 40% |
| ARGOS THERAPEUTICS (ARGS) | 498 | -0.22% | 39% |
| BIOANALYTICAL SYSTEMS (BASI) | 498 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Agilent Technologies, Inc.'s median reaction calculated?
Every labeled A news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 498 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of A's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does A's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.